![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Vol. 12, Issue 3, 675-684, March 2001
Receptor Endocytosis
and Intracellular Sorting Differ between Fibroblasts and Epithelial
Cells
Thoracic Diseases Research Unit and Department of Biochemistry and
Molecular Biology, Mayo Clinic, Rochester, Minnesota 55905
Transforming growth factor-
s (TGF-) are multifunctional
proteins capable of either stimulating or inhibiting mitosis, depending on the cell type. These diverse cellular responses are caused by
stimulating a single receptor complex composed of type I and type II
receptors. Using a chimeric receptor model where the
granulocyte/monocyte colony-stimulating factor receptor ligand binding
domains are fused to the transmembrane and cytoplasmic signaling
domains of the TGF- type I and II receptors, we wished to describe
the role(s) of specific amino acid residues in regulating
ligand-mediated endocytosis and signaling in fibroblasts and epithelial
cells. Specific point mutations were introduced at Y182, T200, and Y249 of the type I receptor and K277 and P525 of the type II receptor. Mutation of either Y182 or Y249, residues within two putative consensus
tyrosine-based internalization motifs, had no effect on endocytosis or
signaling. This is in contrast to mutation of T200 to valine, which
resulted in ablation of signaling in both cell types, while only
abolishing receptor down-regulation in fibroblasts. Moreover, in the
absence of ligand, both fibroblasts and epithelial cells constitutively
internalize and recycle the TGF- receptor complex back to the plasma
membrane. The data indicate fundamental differences between mesenchymal
and epithelial cells in endocytic sorting and suggest that ligand
binding diverts heteromeric receptors from the default recycling pool
to a pathway mediating receptor down-regulation and signaling.
This article has been cited by other articles:
|
|
 |
|
  N. Garamszegi, S. P. Garamszegi, L. A. Shehadeh, and S. P. Scully Extracellular Matrix-Induced Gene Expression in Human Breast Cancer Cells Mol. Cancer Res., March 1, 2009; 7(3): 319 - 329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. C. Finger, N. Y. Lee, H.-j. You, and G. C. Blobe Endocytosis of the Type III Transforming Growth Factor-{beta} (TGF-{beta}) Receptor through the Clathrin-independent/Lipid Raft Pathway Regulates TGF-{beta} Signaling and Receptor Down-regulation J. Biol. Chem., December 12, 2008; 283(50): 34808 - 34818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Song, T. L. Krebs, and D. Danielpour Novel Permissive Role of Epidermal Growth Factor in Transforming Growth Factor beta (TGF-beta) Signaling and Growth Suppression: MEDIATION BY STABILIZATION OF TGF-beta RECEPTOR TYPE II J. Biol. Chem., March 24, 2006; 281(12): 7765 - 7774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Mitchell, A. Choudhury, R. E. Pagano, and E. B. Leof Ligand-dependent and -independent Transforming Growth Factor-{beta} Receptor Recycling Regulated by Clathrin-mediated Endocytosis and Rab11 Mol. Biol. Cell, September 1, 2004; 15(9): 4166 - 4178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Murphy, J. J. E. Dore, M. Edens, R. J. Coffey, J. A. Barnard, H. Mitchell, M. Wilkes, and E. B. Leof Differential Trafficking of Transforming Growth Factor-{beta} Receptors and Ligand in Polarized Epithelial Cells Mol. Biol. Cell, June 1, 2004; 15(6): 2853 - 2862. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Lehmann, P. Seemann, S. Stricker, M. Sammar, B. Meyer, K. Suring, F. Majewski, S. Tinschert, K.-H. Grzeschik, D. Muller, et al. From the Cover: Mutations in bone morphogenetic protein receptor 1B cause brachydactyly type A2 PNAS, October 14, 2003; 100(21): 12277 - 12282. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Janssens, P. ten Dijke, S. H. Ralston, C. Bergmann, and W. Van Hul Transforming Growth Factor-beta 1 Mutations in Camurati-Engelmann Disease Lead to Increased Signaling by Altering either Activation or Secretion of the Mutant Protein J. Biol. Chem., February 21, 2003; 278(9): 7718 - 7724. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Yao, M. Ehrlich, Y. I. Henis, and E. B. Leof Transforming Growth Factor-beta Receptors Interact with AP2 by Direct Binding to beta 2 Subunit Mol. Biol. Cell, November 1, 2002; 13(11): 4001 - 4012. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. S. Seto, H. J. Bellen, and T. E. Lloyd When cell biology meets development: endocytic regulation of signaling pathways Genes & Dev., June 1, 2002; 16(11): 1314 - 1336. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Moustakas, S. Souchelnytskyi, and C.-H. Heldin Smad regulation in TGF-{beta} signal transduction J. Cell Sci., March 14, 2002; 114(24): 4359 - 4369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Garamszegi, J. J. E. Dore Jr., S. G. Penheiter, M. Edens, D. Yao, and E. B. Leof Transforming Growth Factor beta Receptor Signaling and Endocytosis Are Linked through a COOH Terminal Activation Motif in the Type I Receptor Mol. Biol. Cell, September 1, 2001; 12(9): 2881 - 2893. [Abstract] [Full Text] [PDF]
|
|
